These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8027398)

  • 1. Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains.
    Figura N; Armellini D; Bugnoli M; Bayeli PF; Gennari C; Crabtree JE
    J Clin Pathol; 1994 May; 47(5):440-2. PubMed ID: 8027398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activity of cefdinir and omeprazole against Helicobacter pylori and their inhibition on H. pylori-producing urease].
    Yokoya Y; Ikeda F; Mine Y
    Kansenshogaku Zasshi; 1993 Sep; 67(9):808-15. PubMed ID: 8409593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity.
    Mirshahi F; Fowler G; Patel A; Shaw G
    J Clin Pathol; 1998 Mar; 51(3):220-4. PubMed ID: 9659264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of omeprazole on urease activity of Helicobacter pylori in vitro.
    Vogt K; Hahn H
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):273-8. PubMed ID: 8280951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of lansoprazole against Helicobacter pylori.
    Figura N; Crabtree JE; Dattilo M
    J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.
    Yamamoto Y; Hakki A; Friedman H; Okubo S; Shimamura T; Hoffman PS; Rossignol J
    Chemotherapy; 1999; 45(4):303-12. PubMed ID: 10394014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.
    McGowan CC; Cover TL; Blaser MJ
    Gastroenterology; 1994 Nov; 107(5):1573-8. PubMed ID: 7926527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin.
    Cover TL; Puryear W; Perez-Perez GI; Blaser MJ
    Infect Immun; 1991 Apr; 59(4):1264-70. PubMed ID: 2004808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Arch Pharm Res; 1998 Feb; 21(1):6-11. PubMed ID: 9875507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole on Helicobacter pylori urease activity in vivo.
    Stoschus B; Domínguez-Muñoz JE; Kalhori N; Sauerbruch T; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):811-3. PubMed ID: 8864680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs.
    Gismondo MR; Drago L; Lombardi A; Fassina MC; Mombelli B
    J Chemother; 1998 Jun; 10(3):225-30. PubMed ID: 9669648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors.
    Kühler TC; Fryklund J; Bergman NA; Weilitz J; Lee A; Larsson H
    J Med Chem; 1995 Dec; 38(25):4906-16. PubMed ID: 8523404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
    Nagata K; Sone N; Tamura T
    Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
    Sjöström JE; Larsson H
    J Med Microbiol; 1996 Jun; 44(6):425-33. PubMed ID: 8636959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
    Saniee P; Shahreza S; Siavoshi F
    Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents.
    Loo VG; Sherman P; Matlow AG
    Antimicrob Agents Chemother; 1992 May; 36(5):1133-5. PubMed ID: 1510406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant.
    Cover TL; Halter SA; Blaser MJ
    Hum Pathol; 1992 Sep; 23(9):1004-10. PubMed ID: 1381332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.
    McGowan CC; Cover TL; Blaser MJ
    Gastroenterology; 1994 Sep; 107(3):738-43. PubMed ID: 8076759
    [No Abstract]   [Full Text] [Related]  

  • 19. Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.
    Aristoteli LP; O'Rourke JL; Danon S; Larsson H; Mellgard B; Mitchell H; Lee A
    Helicobacter; 2006 Oct; 11(5):460-8. PubMed ID: 16961809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease.
    Baltas N; Karaoglu SA; Tarakci C; Kolayli S
    J Enzyme Inhib Med Chem; 2016; 31(sup2):46-50. PubMed ID: 27233102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.